Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 11, 2010, Pages 2085-2092

  Recipients, Transplant ^a   Evenepoel, Pieter ^a   Bammens, Bert ^a   Claes, Kathleen ^a   Kuypers, Dirk ^a   Meijers, Björn K I ^a   Vanrenterghem, Yves ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BICARBONATE; CALCIFEDIOL; CALCITRIOL; CALCIUM; CALCIUM ION; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENGRAFTMENT; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERCALCEMIA; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TOTAL CALCIUM BLOOD LEVEL;

ACIDOSIS; ADULT; AGED; BELGIUM; BICARBONATES; BIOLOGICAL MARKERS; CALCIUM; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPERCALCEMIA; INCIDENCE; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UP-REGULATION;

EID: 78149326480     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02460310     Document Type: Article

References (49)

1. Toribara T, Terepka A, Dewey P: The ultrafiltrable calcium of human serum. I. Ultrafiltration methods and normal values. J Clin Invest 36: 738-748, 1957
2. Boink A, Buckley B, Christiaensen T, Covington A, Maas A, Müller-Plathe O, Sachs C, Siggaard-Andersen O: Recommendation on sampling, transport, and storage for the determination of the concentration of ionized calcium in whole blood, plasma, and serum. IFC Scientific Division, Working Group on Ion-Selective Electrodes (WGSE). J Int Fed Clin Chem 4: 147-152, 1992
3. Ladenson JH, Lewis JW, Boyd JC: Failure of total calcium corrected protein, albumin, and pH to correctly assess free calcium status. J Clin Endocrinol Metab 46: 986-992, 1978
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113: S1-S130, 2009
5. Gauci C, Moranne O, Fouqueray B, de la Faille R, Maruani G, Haymann JP, Jacquot C, Boffa JJ, Flamant M, Rossert J, Urena P, Stengel B, Souberbielle JC, Froissart M, Houillier P, on behalf of the NephroTest Study Group: Pitfalls of measuring total blood calcium in patients with CKD. J Am Soc Nephrol 19: 1592-1598, 2008
6. Torres A, Lorenzo V, Salido E: Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 13: 551-558, 2002
7. Evenepoel P, Van Den Bergh B, Naesens M, de Jonge H, Bammens B, Claes K, Kuypers D, Vanrenterghem Y: Calcium metabolism in the early posttransplantation period. Clin J Am Soc Nephrol 4: 665-672, 2009
8. Cundy T, Kanis JA, Heynen G, Morris PJ, Oliver DO: Calcium metabolism and hyperparathyroidism after renal transplantation. QJM 52: 67-78, 1983 (Pubitemid 14248199)
9. Ramezani M, Einollahi B, Asl MA, Nafar M, Pourfarziani V, Moradi M, Samadpour A, Alghasi M, Davoudi F: Calcium and phosphorus metabolism disturbances after renal transplantation. Transplant Proc 39: 1033-1035, 2007
10. Stavroulopoulos A, Cassidy MJD, Porter CJ, Hosking DJ, Roe SD: Vitamin D status in renal transplant recipients. Am J Transplant 7: 2546-2552, 2007
11. Reinhardt W, Bartelworth H, Jockenhövel F, Schmidt-Gayk H, Witzke O, Wagner K, Heemann UW, Reinwein D, Philipp T, Mann K: Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 13: 436-442, 1998
12. Bouillon R, De Moor P, Baggiolini EG, Uskokovic MR: A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Chem 26: 562-567, 1980
13. Bouillon R, Van Herck E, Jans I, Tan BK, Van Baelen H, De Moor P: Two direct (nonchromatographic) assays for 25-hydroxyvitamin D. Clin Chem 30: 1731-1736, 1984 (Pubitemid 15116038)
14. Bouillon R, Coopmans W, Degroote DE, Radoux D, Eliard PH: Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. Clin Chem 36: 271-276, 1990
15. Bosma RJ, Doorenbos CRC, Stegeman CA, Homan van der Heide JJ, Navis G: Predictive performance of renal function equations in renal transplant recipients: An analysis of patient factors in bias. Am J Transplant 5: 2193-2203, 2005
16. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 33: 159-174, 1977
17. Clase CM, Norman GL, Beecroft ML, Churchill DN: Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrol Dial Transplant 15: 1841-1846, 2000
18. Siggaard-Andersen O, Thode J, Wandrup J: The concentration of free calcium ions in the blood plasma ionized calcium. In: Blood pH, Carbon Dioxide, Oxygen and Calcium Ion. Proc. 5. of the 1980 Meeting of the IFCC Expert Panel on pH and Blood Gases. Copenhagen, Radiometer Private Press, 1981, pp 164-190
19. Goransson LG, Skadberg O, Bergrem H: Albumin-corrected or ionized calcium in renal failure? What to measure? Nephrol Dial Transplant 20: 2126-2129, 2005
20. Vezzoli G, Elli A, Palazzi P, Bertoni T, Scabini M, Quarto di Palo F, Bianchi G: High plasma ionized calcium with normal PTH and total calcium levels in normal-function kidney transplant recipients. Nephron 42: 290-294, 1986
21. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y: Natural history of parathyroid function and calcium metabolism after kidney transplantation: A single-centre study. Nephrol Dial Transplant 19: 1281-1287, 2004
22. Schwartz GH, David DS, Riggio RR, Saville PD, Whitsell JC, Stenzel KH, Rubin AL: Hypercalcemia after renal transplantation. Am J Med 49: 42-51, 1970
23. Ansell D, Udayaraj UP, Steenkamp R, Dudley CR: Chronic renal failure in kidney transplant recipients. Do they receive optimum care?: Data from the UK renal registry. Am J Transplant 7: 1167-1176, 2007 (Pubitemid 46643098)
24. Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, M'rad MB, Jacquot C, Houillier P, Stengel B, Fouqueray B, the NephroTest Study Group: Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 20: 164-171, 2009
25. Schwarz C, Benesch T, Kodras K, Oberbauer R, Haas M: Complete renal tubular acidosis late after kidney transplantation. Nephrol Dial Transplant 21: 2615-2620, 2006
26. Ambühl PM: Posttransplant metabolic acidosis: A neglected factor in renal transplantation? Curr Opin Nephrol Hypertens 16: 379-387, 2007
27. Lopez Aquilera-Tejero E, Felsenfeld AJ, Estepa J, Rodriguez M: Direct effect of acute metabolic and respiratory acidosis on parathyroid hormone secretion in the dog. J Bone Miner Res 17: 1691-1700, 2002
28. Graham KA, Hoenich NA, Tarbit M, Ward MK, Goodship TH: Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. J Am Soc Nephrol 8: 627-631, 1997
29. Lopez I, Guilera-Tejero E, Estepa JC, Rodriguez M, Felsenfeld AJ: Role of acidosis-induced increases in calcium on PTH secretion in acute metabolic and respiratory acidosis in the dog. Am J Physiol Endocrinol Metab 286: E780-E785, 2004
30. Kraut JA, Kurtz I: Metabolic acidosis of CKD: Diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 45: 978-993, 2005
31. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM: Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20: 2075-2084, 2009
32. David DS, Sakal S, Brennan L, Riggio RA, Cheigh J, Stenzel KH, Rubin AL, Sherwood LM: Hypercalcemia after renal transplantation. Long-term follow-up data. N Engl J Med 289: 398-401, 1973
33. Bonarek H, Merville P, Bonarek M, Moreau K, Morel D, Aparicio M, Potaux L: Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int 56: 642-649, 1999
34. Özdemir FN, Afsar B, Akgul A, Usluogullari C, Akçay A, Haberal M: Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc 38: 480-482, 2006
35. Gwinner W, Suppa S, Mengel M, Hoy L, Kreipe HH, Haller H, Schwarz A: Early calcification of renal allografts detected by protocol biopsies: Causes and clinical implications. Am J Transplant 5: 1934-1941, 2005
36. Vervaet BA, Verhulst A, D'Haese PC, De Broe ME: Nephrocalcinosis: New insights into mechanisms and consequences. Nephrol Dial Transplant 24: 2030-2035, 2009
37. Evenepoel P, Lerut E, Naesens M, Bammens B, Claes K, Kuypers D, Vermeersch P, Meijers BKI, Van Damme B, Vanrenterghem Y: Localization, etiology and impact of calcium phosphate deposits in renal allografts. Am J Transplant 9: 2470-2478, 2009
38. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15: 2857-2867, 2004
39. Schaeffner ES, Födinger M, Kramar R, Sunder-Plassmann G, Winkelmayer C: Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transplant Int 20: 247-255, 2007 (Pubitemid 46246543)
40. Egbuna O, Taylor J, Buchinsky D, Zand M: Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant 21: 558-566, 2007
41. Evenepoel P, Claes K, Kuypers DR, Debruyne F, Vanrenterghem Y: Parathyroidectomy after successful kidney transplantation: A single centre study. Nephrol Dial Transplant 22: 1730-1737, 2007
42. Triponez H, Clark OH, Vanrenterghem Y, Evenepoel P: Surgical treatment of persistent hyperparathyroidism after transplantation. Ann Surg 248: 18-30, 2008
43. Serra AL, Savoca R, Huber AR, Hepp U, Delsignore A, Hersberger M, Wuthrich RP: Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant 22: 577-583, 2007
44. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG: Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 22: 2362-2365, 2007
45. Srinivas TR, Schold JD, Womer KL, Kaplan B, Howard RJ, Bucci CM, Meier-Kriesche HU: Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol 1: 323-326, 2006
46. Leca N, Laftavi M, Gundroo A, Kohli R, Min I, Karam J, Sridhar N, Blessios G, Venuto R, Pankewycz O: Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Am J Transplant 6: 2391-2395, 2006
47. El-Amm JM, Doshi MD, Singh A, Migdal S, Morawski K, Sternbauer D, Cincotta E, West MS, Losanoff JE, Gruber SA: Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation. Transplantation 83: 546-549, 2007
48. Szwarc I, Argiles A, Garrique V, Delmas S, Chong G, Deleuze S, Mourad G: Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 82: 675-680, 2006
49. Bergua C, Torregrosa J-V, Cofan F, Oppenheimer F: Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism. Transplant Proc 39: 2254-2255, 2007 (Pubitemid 47418225)